Human antibodies binding to ROR2
US11447546B2 · kind B2 · utility
1Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2018 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Nov 6, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fully human antibodies and conjugates thereof, which specifically bind to the extracellular domain of receptor tyrosine kinase-like orphan receptor 2 (ROR2).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.